CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus

Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park

Clin Mol Hepatol. 2011;17(3):199-205. Published online 2011 September 30 DOI: https://doi.org/10.3350/kjhep.2011.17.3.199

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus

Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park

The Korean Journal of Hepatology. 2011;17(3):199

Link1 Link2 Link3

A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C

M. Buti, M. Medina, M. A. Casado, J. B. Wong, L. Fosbrook, R. Esteban

Alimentary Pharmacology & Therapeutics. 2003;17(5):687-694

Link1 Link2 Link3

Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients

Youn Jae Lee

The Korean Journal of Hepatology. 2008;14(4):443

Link1 Link2 Link3

Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH, M. L. SHIFFMAN

Alimentary Pharmacology & Therapeutics. 2007;27(5):433-440

Link1 Link2

PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

M. Fonseca, G. Tannus, E. Parisi

Value in Health. 2012;15(4):A139

Link1 Link2

PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I Infection

M. Fonseca, G. Tannus, E. Parisi

Value in Health. 2012;15(4):A139

Link1 Link2

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

Maria Buti, Francisco Sanchez-Avila, Yoav Lurie, Carlos Stalgis, Auristela Valdés, Maria Martell, Rafael Esteban

Hepatology. 2002;35(4):930-936

Link1 Link2 Link3

PGI16 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

M. Fonseca, V. Garran, G.T. Araujo

Value in Health. 2012;15(7):A328

Link1 Link2

PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

M. Fonseca, V. Garran, G.T. Araujo

Value in Health. 2012;15(7):A329

Link1 Link2

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

G Davis

Hepatology. 2003;38(3):645-652

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.